What is Healthcare Triangle, Inc.'s earnings per share (EPS)?

Healthcare Triangle, Inc. (HCTI) reported diluted earnings per share of -$152.30 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Healthcare Triangle, Inc. (HCTI) Financials

HCTI

FY2025 annual

Revenue $13.9M +18.8% YoY

Net Income -$9.5M -58.8% YoY

EPS (Diluted) -$152.30 YoY not available

Free Cash Flow -$16.5M YoY not available

Market Cap $7.1M as of Oct 10, 2026

Price / Sales 0.3x on $25.7M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.1x on $49.1M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 13, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HCTI SEC filings page.

Healthcare Triangle, Inc. (HCTI) reported $13.9M in revenue for fiscal year 2025, up 18.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HCTI FY2025 2026-10-04

FY2025’s revenue recovery did not improve economics: lower gross margins and heavier operating losses made financing more important.

Cash conversion deteriorated sharply: operating cash flow moved from a deficit of $1.1M in FY2024 to $16.5M in FY2025, while free cash flow was nearly identical to operating cash flow. That alignment indicates the reported cash pressure came mainly from operations rather than unusually heavy capital spending.

Growth came with weaker unit economics: revenue increased 18.8% from FY2024, but gross margin fell from 24.7% to 13.6%. The combination points to a less profitable revenue mix or higher delivery costs, rather than growth absorbing fixed costs efficiently.

The balance sheet was rebuilt through financing: FY2025 financing cash flow was $25.9M, alongside positive equity of $9.9M after negative equity in FY2024. Yet the current ratio was only 1.0x and the reported liquidity measure equaled 5.5 months of the latest annual operating outflow, leaving the business dependent on continued capital access while losses remain substantial.

Financial Health Signals

Financial Health Score 30/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Healthcare Triangle, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Healthcare Triangle, Inc. held $7.6M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $16.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Healthcare Triangle, Inc. scores 20/100 among other emerging companies.

Dilution

Healthcare Triangle, Inc. had 2M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Healthcare Triangle, Inc. scores 82/100 among other emerging companies.

R&D Intensity

Healthcare Triangle, Inc. spent $536K on research and development in fiscal year 2025, which was 2.3% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Healthcare Triangle, Inc. scores 14/100 among other emerging companies.

Revenue Progress

Healthcare Triangle, Inc. reported revenue of $13.9M in fiscal year 2025, against $11.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Healthcare Triangle, Inc. scores 11/100 among other emerging companies.

Burn Trend

Healthcare Triangle, Inc.'s operations used $16.5M of cash in fiscal year 2025, against $1.1M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Healthcare Triangle, Inc. scores 5/100 among other emerging companies.

Balance Sheet

Healthcare Triangle, Inc.'s cash, cash equivalents and investments came to $7.6M at the end of fiscal year 2025, against $12.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Healthcare Triangle, Inc. scores 46/100 among other emerging companies.

Altman Z-Score Distress

-3.11

Healthcare Triangle, Inc. scores -3.11, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($7.1M) relative to total liabilities ($12.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/8

Healthcare Triangle, Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Healthcare Triangle, Inc. reported a net loss of $9.5M while operations used $16.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Healthcare Triangle, Inc. reported an operating loss of $9.8M against $567K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$9.2M

YoY+158.4%

QoQ-6.7%

5Y CAGR-1.8%

Healthcare Triangle, Inc. generated $9.2M in revenue in Q2 2026. This represents an increase of 158.4% from the same quarter a year earlier. Against the prior quarter it is down 6.7%.

EBITDA

-$3.5M

YoY-160.6%

QoQ-25.9%

Healthcare Triangle, Inc.'s EBITDA was -$3.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 160.6% from the same quarter a year earlier. Against the prior quarter it is down 25.9%.

Net Income

-$4.4M

YoY-223.0%

QoQ+28.8%

Healthcare Triangle, Inc. reported -$4.4M in net income in Q2 2026. This represents a decrease of 223.0% from the same quarter a year earlier. Against the prior quarter it is up 28.8%.

EPS (Diluted)

-$1.56

Healthcare Triangle, Inc. earned -$1.56 per diluted share (EPS) in Q2 2026.

Cash & Balance Sheet

Cash & Debt

$1.9M

YoY-41.0%

QoQ-55.8%

5Y CAGR+4.2%

Healthcare Triangle, Inc. held $1.9M in cash against $8.1M in long-term debt as of Q2 2026.

Shares Outstanding

15M

Healthcare Triangle, Inc. had 15M shares outstanding in Q2 2026.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

22.5%

YoY+8.6pp

QoQ-1.8pp

5Y change-10.8pp

Healthcare Triangle, Inc.'s gross margin was 22.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 8.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.

Operating Margin

-44.3%

YoY-6.1pp

QoQ-7.5pp

5Y change-49.0pp

Healthcare Triangle, Inc.'s operating margin was -44.3% in Q2 2026, reflecting core business profitability. This is down 6.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.5 percentage points.

Net Margin

-48.0%

YoY-9.6pp

QoQ+14.9pp

5Y change-51.0pp

Healthcare Triangle, Inc.'s net profit margin was -48.0% in Q2 2026, showing the share of revenue converted to profit. This is down 9.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.9 percentage points.

Return on Equity

-9.0%

YoY+4.4pp

QoQ+2.8pp

Healthcare Triangle, Inc.'s ROE was -9.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.8 percentage points.

Capital Allocation

R&D Spending

$51K

YoY-7.3%

QoQ-40.0%

5Y CAGR-42.5%

Healthcare Triangle, Inc. invested $51K in research and development in Q2 2026. This represents a decrease of 7.3% from the same quarter a year earlier. Against the prior quarter it is down 40.0%.

Share Buybacks

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

HCTI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCTI quarterly income statement

Metric	TTM	FY2510-K/A	FY2410-K/A	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	$25.7M	$13.9M+18.8%	$11.7M-64.8%	$33.2M-27.6%	$45.9M+30.1%	$35.3M+12.5%	$31.3M
Cost of Revenue	$20.1M	$12.0M+36.3%	$8.8M-66.7%	$26.4M-23.6%	$34.6M+39.8%	$24.7M+8.8%	$22.8M
Gross Profit	$5.5M	$1.9M-34.6%	$2.9M-57.4%	$6.8M-40.0%	$11.3M+7.3%	$10.5M+22.6%	$8.6M
R&D Expenses	$473K	$536K+24.9%	$429K-46.3%	$799K-90.2%	$8.1M+54.8%	$5.3M+201.6%	$1.7M
SG&A Expenses	$13.0M	$7.3M+85.7%	$4.0M-31.0%	$5.7M	$0	$0-100.0%	$2.4M
Operating Income	-$14.7M	-$9.8M-106.0%	-$4.8M+38.3%	-$7.7M+52.9%	-$16.3M-204.6%	-$5.4M-555.3%	$1.2M
EBITDA	N/A	-$9.1M-135.2%	-$3.9M+37.0%	-$6.1M+54.2%	-$13.4M-240.0%	-$3.9M-298.8%	$2.0M
Interest Expense	$272K	$567K+146.7%	-$1.2M-225.3%	$968K+356.6%	$212K-62.6%	$567K+621.0%	$79K
Income Tax	N/A	N/A	$12K-65.7%	$35K-93.1%	$506K+2008.3%	$24K-90.7%	$257K
Net Income	-$17.0M	-$9.5M-58.8%	-$6.0M+31.3%	-$8.7M+39.5%	-$14.4M-141.4%	-$5.9M-352.8%	$2.4M
EPS (Basic)	N/A	-$152.30+99.1%	-$16909.30-812847.1%	-$2.08+46.4%	-$3.88-1820.8%	-$0.20-340.5%	$0.08
EPS (Diluted)	—	-$152.30	-$16909.30	-$2.08	-$3.88	-$0.20-340.5%	$0.08
Diluted Shares (Avg)	N/A	61,873	353	4M	4M	29M+5.5%	28M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-Q
Revenue	$9.2M+158.4%	$9.9M+166.1%	$3.1M+43.4%	$3.5M+44.6%	$3.6M+19.2%	$3.7M-9.9%	$2.2M-69.0%	$2.4M-69.0%
Cost of Revenue	$7.1M+132.6%	$7.5M+121.1%	$2.7M+39.1%	$2.9M+69.8%	$3.1M+46.9%	$3.4M+9.0%	$1.9M-65.0%	$1.7M-72.2%
Gross Profit	$2.1M+318.4%	$2.4M+627.4%	$449K+75.4%	$618K-14.4%	$494K-45.0%	$329K-67.6%	$256K-83.3%	$722K-57.7%
R&D Expenses	$51K-7.3%	$85K-41.0%	$278K+247.5%	$59K-66.3%	$55K-73.4%	$144K+13.4%	-$80K-23.1%	$175K+224.1%
SG&A Expenses	$4.8M+307.9%	$3.2M+168.5%	$2.9M+264.5%	$2.1M+93.6%	$1.2M+30.8%	$1.2M+1.4%	$788K-29.8%	$1.1M-21.0%
Operating Income	-$4.1M-199.6%	-$3.6M-159.2%	-$4.4M-800.8%	-$2.6M-122.0%	-$1.4M+1.4%	-$1.4M+18.4%	-$493K+63.9%	-$1.2M+23.4%
EBITDA	-$3.5M-160.6%	-$2.8M-103.0%	-$3.8M-274.7%	-$2.5M-206.8%	-$1.4M-61.0%	-$1.4M-17.8%	-$1.0M+53.5%	-$824K-1.5%
Interest Expense	-$89K-323.8%	$89K-71.8%	$304K+135.6%	-$32K+60.0%	-$21K+84.0%	$316K+312.1%	-$853K-152.3%	-$80K+80.7%
Income Tax	$24K	N/A	N/A	N/A	N/A	N/A	$4K-42.9%	$2K-50.0%
Net Income	-$4.4M-223.0%	-$6.2M-264.6%	-$4.5M-234.1%	-$1.9M-52.6%	-$1.4M+9.5%	-$1.7M+8.7%	-$1.3M+19.7%	-$1.2M+35.7%
EPS (Basic)	-$1.56+95.5%	-$6.81-3905.9%	-$150.07-65147.8%	-$0.42+99.2%	-$35.01+50.5%	-$0.17+59.5%	-$0.23+46.5%	-$54.78-12073.3%
EPS (Diluted)	-$1.56	-$6.81	-$150.07	-$0.42	-$35.01	-$0.17	-$0.23	-$54.78
Diluted Shares (Avg)	3M	930,672	N/A	4M	39,057	659	N/A	22,756

HCTI Balance Sheet

HCTI quarterly balance sheet

Metric	FY2510-K/A	FY2410-K/A	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$22.7M+1059.4%	$2.0M-71.4%	$6.9M-48.3%	$13.3M-46.1%	$24.6M+121.6%	$11.1M
Current Assets	$13.2M+805.7%	$1.5M-74.3%	$5.7M-29.5%	$8.0M-32.0%	$11.8M+47.0%	$8.0M
Cash & Equivalents	$7.6M+38025.0%	$20K-98.4%	$1.2M-8.0%	$1.3M-24.2%	$1.8M+26.2%	$1.4M
Short-Term Investments	$0	$0	$0	$0	$0	$0
Accounts Receivable	$2.1M+86.5%	$1.1M-69.1%	$3.6M-38.7%	$5.9M-39.4%	$9.7M+51.2%	$6.4M
Long-Term Investments	$0	$0	$0	$0	$0	$0
Goodwill	$2.9M	N/A	N/A	$1.3M0.0%	$1.3M	N/A
Total Liabilities	$12.8M+80.8%	$7.1M+11.9%	$6.3M-12.5%	$7.2M-14.8%	$8.5M+25.1%	$6.8M
Current Liabilities	$12.8M+80.8%	$7.1M	N/A	$6.6M+5.5%	$6.3M-7.8%	$6.8M
Non-Current Liabilities	$0	$0+100.0%	-$1.8M-393.1%	$625K-71.9%	$2.2M	$0
Long-Term Debt	N/A	N/A	$888K	N/A	N/A	N/A
Total Equity	$9.9M+294.4%	-$5.1M-1050.6%	$538K-91.1%	$6.0M-57.6%	$14.2M+229.0%	$4.3M
Retained Earnings	-$43.0M-28.1%	-$33.6M-21.6%	-$27.6M-45.9%	-$18.9M-610.1%	-$2.7M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-Q
Total Assets	$73.6M+405.5%	$80.2M+580.2%	$22.7M+1059.4%	$13.8M+190.3%	$14.6M+142.0%	$11.8M+71.5%	$2.0M-71.4%	$4.8M-67.1%
Current Assets	$9.6M+8.8%	$18.9M+92.0%	$13.2M+805.7%	$7.9M+345.2%	$8.9M+280.0%	$9.8M+210.5%	$1.5M-74.3%	$1.8M-63.5%
Cash & Equivalents	$1.9M-41.0%	$4.3M-36.8%	$7.6M+38025.0%	$1.6M+5717.9%	$3.2M+11031.0%	$6.8M+2167.8%	$20K-98.4%	$28K-62.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$6.2M+232.2%	$8.4M+338.8%	$2.1M+86.5%	$2.4M+51.6%	$1.9M-7.1%	$1.9M-9.0%	$1.1M-69.1%	$1.6M+40150.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$2.9M0.0%	$2.9M	$2.9M	N/A	$2.9M	N/A	N/A	N/A
Total Liabilities	$24.5M+463.0%	$27.5M+756.1%	$12.8M+80.8%	$5.1M-22.4%	$4.4M-34.6%	$3.2M-56.5%	$7.1M+11.9%	$6.6M-21.0%
Current Liabilities	$16.0M+406.2%	$21.0M+554.4%	$12.8M+80.8%	$3.9M-35.7%	$3.2M-48.8%	$3.2M-46.5%	$7.1M	$6.1M-11.2%
Non-Current Liabilities	$8.6M+612.6%	$6.5M	$0	$1.2M+140.0%	$1.2M+140.0%	$0-100.0%	$0+100.0%	$500K-66.4%
Long-Term Debt	$8.1M	$629K	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$49.1M+380.9%	$52.7M+514.4%	$9.9M+294.4%	$8.7M+580.0%	$10.2M+1680.3%	$8.6M+1778.5%	-$5.1M-1050.6%	-$1.8M-129.7%
Retained Earnings	-$53.5M-46.0%	-$49.3M-39.9%	-$43.0M-28.1%	-$38.5M-30.5%	-$36.6M-29.6%	-$35.3M-31.8%	-$33.6M-21.6%	-$29.5M-50.8%

Not reported in any period shown, so not listed: Inventory.

HCTI Cash Flow Statement

HCTI quarterly cash flow statement

Metric	TTM	FY2510-K/A	FY2410-K/A	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	-$16.0M	-$16.5M-1428.5%	-$1.1M+49.7%	-$2.2M+59.8%	-$5.4M+24.7%	-$7.1M-868.0%	-$735K
Depreciation & Amortization	N/A	$705K-20.7%	$889K-43.2%	$1.6M-46.8%	$2.9M+106.9%	$1.4M+77.0%	$803K
Stock-Based Compensation	N/A	$451K+418.4%	$87K-47.6%	$166K-35.4%	$257K+394.2%	$52K	N/A
Capital Expenditures	N/A	$6K	N/A	$12K-70.0%	$40K	N/A	N/A
Free Cash Flow	N/A	-$16.5M	N/A	-$2.2M+59.9%	-$5.4M	N/A	N/A
Investing Cash Flow	-$10.4M	-$1.8M	N/A	-$12K+98.9%	-$1.1M+85.1%	-$7.6M-1497.8%	-$477K
Financing Cash Flow	$25.1M	$25.9M+19557.9%	-$133K-106.5%	$2.1M-66.1%	$6.1M-59.9%	$15.1M+821.2%	$1.6M
Share Buybacks	N/A	N/A	N/A	N/A	$141K	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-Q
Operating Cash Flow	-$833K+68.4%	-$6.9M-23.5%	-$6.8M-742.7%	-$1.5M-309.4%	-$2.6M-181.8%	-$5.6M-11014.0%	-$811K-235.4%	$715K
Depreciation & Amortization	$529K	$810K+6650.0%	$630K+534.5%	$63K-81.6%	$0-100.0%	$12K-97.8%	-$145K+82.4%	$343K-51.8%
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	$36K+38.5%	N/A	N/A
Capital Expenditures	N/A	$22K	$0	$3K	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$6.9M	-$6.8M	-$1.5M	N/A	N/A	N/A	N/A
Investing Cash Flow	-$3.2M	-$6.0M	-$462K	-$686K	N/A	N/A	N/A	N/A
Financing Cash Flow	$1.7M+576.1%	$9.5M-23.3%	$13.3M+1555.3%	$584K+181.6%	-$360K-154.3%	$12.4M+1500.1%	$803K+42.1%	-$716K-1276.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

HCTI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCTI quarterly financial ratios

Metric	FY2510-K/A	FY2410-K/A	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Gross Margin	13.6%-11.1pp	24.7%+4.3pp	20.4%-4.2pp	24.6%-5.2pp	29.8%+2.4pp	27.4%
Operating Margin	-70.5%-29.8pp	-40.6%-17.4pp	-23.2%+12.4pp	-35.6%-20.4pp	-15.2%-18.9pp	3.8%
Net Margin	-68.2%-17.2pp	-51.0%-24.9pp	-26.2%+5.1pp	-31.3%-14.4pp	-16.9%-24.4pp	7.5%
Return on Equity	-95.3%	N/A	-1614.5%-1376.8pp	-237.7%-196.0pp	-41.8%-96.2pp	54.4%
Return on Assets	-41.7%+262.7pp	-304.4%-177.7pp	-126.7%-18.4pp	-108.3%-84.1pp	-24.2%-45.4pp	21.2%
Current Ratio	1.03+0.8x	0.21	N/A	1.22-0.7x	1.89+0.7x	1.18
Debt-to-Equity	1.29	N/A	1.65+0.5x	1.20+0.6x	0.60-1.0x	1.57
Asset Turnover	0.61-5.4x	5.96+1.1x	4.84+1.4x	3.46+2.0x	1.43-1.4x	2.82
FCF Margin	-119.0%	N/A	-6.5%+5.2pp	-11.8%	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-Q
Gross Margin	22.5%+8.6pp	24.3%+15.4pp	14.3%+2.6pp	17.7%-12.2pp	13.9%-16.2pp	8.9%-15.8pp	11.7%-10.0pp	29.9%+8.0pp
Operating Margin	-44.3%-6.1pp	-36.8%+1.0pp	-141.4%	-74.3%-25.9pp	-38.2%+8.0pp	-37.7%+3.9pp	-22.5%-3.1pp	-48.4%-28.8pp
Net Margin	-48.0%-9.6pp	-62.9%-17.0pp	-143.4%	-54.6%-2.9pp	-38.4%+12.2pp	-45.9%-0.6pp	-61.6%-37.8pp	-51.8%-26.8pp
Return on Equity	-9.0%+4.4pp	-11.8%+8.1pp	-45.3%	-21.8%	-13.4%	-19.8%	N/A	N/A
Return on Assets	-6.0%+3.4pp	-7.7%+6.7pp	-19.8%+48.9pp	-13.8%+12.4pp	-9.4%+15.7pp	-14.4%+12.7pp	-68.7%-44.3pp	-26.2%-12.8pp
Current Ratio	0.60-2.2x	0.90-2.2x	1.03+0.8x	2.03+1.7x	2.81+2.4x	3.07+2.5x	0.21	0.29-0.4x
Debt-to-Equity	0.17-0.3x	0.01-0.4x	1.29	0.59	0.43	0.37	N/A	N/A
Asset Turnover	0.12-0.1x	0.12-0.2x	0.14-1.0x	0.25-0.3x	0.24-0.3x	0.31-0.3x	1.12+0.1x	0.510.0x
FCF Margin	N/A	-69.9%	-217.6%	-43.0%	N/A	N/A	N/A	N/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Healthcare Triangle, Inc. HCTI	FY2025	$13.9M	-$9.5M	-68.2%	$7.1M	30/100
VSEE HEALTH INC VSEE	FY2025	$14.6M	-$14.7M	N/A	$4.7M	—
DarioHealth Corp. DRIO	FY2025	$22.4M	-$41.7M	N/A	$56.8M	54/100
Bullfrog AI Holdings, Inc. BFRG	FY2025	$117K	-$6.5M	N/A	$12.0M	—
Mangoceuticals, Inc. MGRX	FY2025	$456K	-$20.6M	N/A	$9.1M	—

Where Healthcare Triangle, Inc. Ranks

Frequently Asked Questions

What is Healthcare Triangle, Inc.'s annual revenue?

Healthcare Triangle, Inc. (HCTI) reported $13.9M in total revenue for fiscal year 2025. This represents a 18.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthcare Triangle, Inc.'s revenue growing?

Healthcare Triangle, Inc. (HCTI) revenue grew by 18.8% year-over-year, from $11.7M to $13.9M in fiscal year 2025.

Is Healthcare Triangle, Inc. profitable?

No, Healthcare Triangle, Inc. (HCTI) reported a net income of -$9.5M in fiscal year 2025, with a net profit margin of -68.2%.

What is Healthcare Triangle, Inc.'s EBITDA?

Healthcare Triangle, Inc. (HCTI) had EBITDA of -$9.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Healthcare Triangle, Inc.'s gross margin?

Healthcare Triangle, Inc. (HCTI) had a gross margin of 13.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Healthcare Triangle, Inc.'s operating margin?

Healthcare Triangle, Inc. (HCTI) had an operating margin of -70.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Healthcare Triangle, Inc.'s net profit margin?

Healthcare Triangle, Inc. (HCTI) had a net profit margin of -68.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Healthcare Triangle, Inc.'s return on equity (ROE)?

Healthcare Triangle, Inc. (HCTI) has a return on equity of -95.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthcare Triangle, Inc.'s free cash flow?

Healthcare Triangle, Inc. (HCTI) recorded an outflow of $16.5M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Healthcare Triangle, Inc.'s operating cash flow?

Healthcare Triangle, Inc. (HCTI) recorded an outflow of $16.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Healthcare Triangle, Inc.'s total assets?

Healthcare Triangle, Inc. (HCTI) had $22.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Healthcare Triangle, Inc.'s capital expenditures?

Healthcare Triangle, Inc. (HCTI) invested $6K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Healthcare Triangle, Inc. spend on research and development?

Healthcare Triangle, Inc. (HCTI) invested $536K in research and development during fiscal year 2025.

How many shares does Healthcare Triangle, Inc. have outstanding?

Healthcare Triangle, Inc. (HCTI) had 2M shares outstanding as of fiscal year 2025.

What is Healthcare Triangle, Inc.'s current ratio?

Healthcare Triangle, Inc. (HCTI) had a current ratio of 1.03 as of fiscal year 2025, which is considered adequate.

What is Healthcare Triangle, Inc.'s debt-to-equity ratio?

Healthcare Triangle, Inc. (HCTI) had a debt-to-equity ratio of 1.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthcare Triangle, Inc.'s return on assets (ROA)?

Healthcare Triangle, Inc. (HCTI) had a return on assets of -41.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthcare Triangle, Inc.'s P/E ratio?

Healthcare Triangle, Inc. (HCTI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $7.1M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthcare Triangle, Inc.'s price-to-sales ratio?

Healthcare Triangle, Inc. (HCTI) trades at 0.3x sales, its market capitalization divided by revenue of $25.7M revenue, trailing 12 months to June 30, 2026. The market capitalization is $7.1M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Healthcare Triangle, Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Healthcare Triangle, Inc. (HCTI) held $7.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $16.5M over that year. Dividing the one by the other, the reported balance equals about 6 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Healthcare Triangle, Inc.'s Altman Z-Score?

Healthcare Triangle, Inc. (HCTI) has an Altman Z-Score of -3.11, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Healthcare Triangle, Inc.'s Piotroski F-Score?

Healthcare Triangle, Inc. (HCTI) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthcare Triangle, Inc.'s earnings high quality?

Healthcare Triangle, Inc. (HCTI) reported a net loss of $9.5M while operations used $16.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Healthcare Triangle, Inc. cover its interest payments?

Healthcare Triangle, Inc. (HCTI) reported an operating loss of $9.8M against $567K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Healthcare Triangle, Inc.?

Healthcare Triangle, Inc. (HCTI) scores 30 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.